Related references
Note: Only part of the references are listed.Blood Pressure Control by Drug Group in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
William C. Cushman et al.
JOURNAL OF CLINICAL HYPERTENSION (2008)
The lifetime risk of stroke - Estimates from the Framingham Study
S Seshadri et al.
STROKE (2006)
Evaluating bias due to population stratification in case-control association studies of admixed populations
YT Wang et al.
GENETIC EPIDEMIOLOGY (2004)
Influences of matrix metalloproteinase-3 gene variation on extent of coronary atherosclerosis and risk of myocardial infarction
S Beyzade et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Matrix metalloproteinase-3 genotype contributes to age-related aortic stiffening through modulation of gene and protein expression
TL Medley et al.
CIRCULATION RESEARCH (2003)
Genetic variations of matrix metalloproteinase-1 and-3 promoter regions and their associations with susceptibility to myocardial infarction in Japanese
T Nojiri et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2003)
Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with carotid artery stenosis
G Ghilardi et al.
STROKE (2002)
Carotid intima-media thickness is associated with allelic variants of stromelysin-1, interleukin-6, and hepatic lipase genes - The Northern Manhattan Prospective Cohort Study
T Rundek et al.
STROKE (2002)
Large artery stiffness: Structural and genetic aspects
BA Kingwell et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2001)
Share Paper
